Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation

Updated:Feb 20,2013
PON_ScienceNews_DiscussThis



Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

Circ Journal Cover for Science News

  • Cardiovascular disease is a major cause of morbidity and mortality for those with end-stage non-cardiac organ failure both before and after transplantation.
  • The unique characteristics of end-organ failure transplant candidates require careful consideration during cardiac evaluation.
  • This paper addresses gaps in existing guidelines for consideration during cardiac disease evaluation in kidney and liver transplant candidates.
 
Read the full article in Circulation
Circulation. 2012: published online before print July 2, 2012, 10.1161/CIR.0b013e31823eb07a.

Supporting Materials
  • Commentary:  Bringing Harmony to the Cacophony of Cardiovascular Disease Assessment for Potential Kidney Liver Transplant Candidates. A Case for Assimilating the New AHA/ACCF Guidelines by Christopher deFilippi, MD
  • Top 10 Things To Know
Other Resources
Related Statements and Guidelines

Did you see these recent Commentaries?

Commentaries View All


Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Network with over 31,000 Heart and Stroke Professionals

  • Connect with others around the world
  • Share and discuss articles by prominent heart and stroke researchers
     
    Join the AHA's Professional Online Network at networking.americanheart.org    Login to AHA's Professional Online Network at networking.americanheart.org